Activity Number:
|
511
- In Pursuit of Speed and Efficiency in New Drug Development: Statistical Designs at the Forefront of Pushing the Boundaries of Innovation
|
Type:
|
Topic Contributed
|
Date/Time:
|
Thursday, August 11, 2022 : 8:30 AM to 10:20 AM
|
Sponsor:
|
Biometrics Section
|
Abstract #320821
|
|
Title:
|
Two-Stage Optimal Designs Based on Exact Variance for a Single-Arm Trial with Survival Endpoints
|
Author(s):
|
Guogen Shan*
|
Companies:
|
University of Florida
|
Keywords:
|
Cancer trials ;
Exact variance;
One sample log rank test;
optimal designs;
two stage designs
|
Abstract:
|
Sample size calculation based on normal approximations is often associated with the loss of statistical power for a single-arm trial with a time-to-event endpoint. Recently, Wu (2015) derived the exact variance for the one-sample log-rank test under the alternative and showed that a single-arm one-stage study based on exact variance often has power above the nominal level while the type I error rate is controlled. We extend this approach to a single-arm two-stage design by using exact variances of the one-sample log-rank test for the first stage and the two stages combined. The empirical power of the proposed two-stage optimal designs is often not guaranteed under a two-stage design setting, which could be due to the asymptotic bi-variate normal distribution used to estimate the joint distribution of the test statistics. We adjust the nominal power level in the design search to guarantee the simulated power of the identified optimal design being above the nominal level. The sample size and the study time savings of the proposed two-stage designs are substantial as compared to the one-stage design.
|
Authors who are presenting talks have a * after their name.
Back to the full JSM 2022 program
|